Lv71
3310 积分 2022-11-11 加入
Physiological β‐amyloid clearance by the liver and its therapeutic potential for Alzheimer’s disease
2个月前
已完结
Small-Molecule Ligands Targeting Lysosome-Shuttling Receptors and the Emerging Landscape of Lysosome-Targeting Chimeras
2个月前
已完结
Biomarker-activated multifunctional lysosome-targeting chimeras mediated selective degradation of extracellular amyloid fibrils
2个月前
已完结
Lysosome-Targeting Chimeras: Design, Mechanisms, and Degradation of “Rogue” Proteins
2个月前
已完结
The new direction of drug development: Degradation of undruggable targets through targeting chimera technology
2个月前
已完结
Lysosome-targeting chimeras enable targeted protein degradation
2个月前
已完结
Peritoneal dialysis reduces amyloid-beta plasma levels in humans and attenuates Alzheimer-associated phenotypes in an APP/PS1 mouse model
2个月前
已完结
Amyloid-lowering immunotherapies for Alzheimer disease: current status and future directions
2个月前
已完结
Hospital Budget Impact and Provider-Side Economic Evaluation of Lecanemab and Donanemab Under Japan’s National Fee Schedule: A Head-to-Head Linear Model
2个月前
已完结
The Efficacy and Safety of Amyloid Beta‐Directed Monoclonal Antibodies for Alzheimer's Disease: A Systematic Review and Meta‐Analysis of Phase III Randomized Controlled Trials
2个月前
已完结